| Accession |
PRJCA021813 |
| Title |
Real-World Molecular Testing, Treatment Patterns and Clinical Outcomes in Chinese Stage III NSCLC Patients - A Prospective, Non-Interventional Study |
| Relevance |
Medical |
| Data types |
Map
Transcriptome or Gene expression
|
| Organisms |
Homo sapiens
|
| Description |
Real-World Molecular Testing, Treatment Patterns and Clinical Outcomes in Chinese Stage III NSCLC Patients |
| Sample scope |
Multiisolate |
| Release date |
2024-05-24 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| China AstraZeneca Marketing Company
|
Clinical Study
|
N/A
|
Real-World Molecular Testing, Treatment Patterns and Clinical Outcomes in Chinese Stage III NSCLC Patients - A Prospective, Non-Interventional Study (MOOREA)
|
|
|
| Submitter |
Changchun
Zhou (zcc5858@126.com)
|
| Organization |
Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences |
| Submission date |
2023-12-05 |
